Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

<p><strong>Objective:</strong> To ascertain patient eligibility status and describe coverage of antiviral drugs and neutralising monoclonal antibodies (nMAB) as treatment for covid-19 in community settings in England.</p> <p><strong>Design:</strong> Retrosp...

Full description

Bibliographic Details
Main Authors: Green, ACA, Curtis, HJ, Higgins, R, Nab, L, Mahalingasivam, V, Smith, RM, Mehrkar, A, Inglesby, P, Drysdale, H, DeVito, NJ, Croker, R, Rentsch, CT, Bhaskaran, K, Tazare, J, Zheng, B, Andrews, CD, Bacon, SCJ, Davy, S, Dillingham, I, Evans, D, Fisher, L, Hickman, G, Hopcroft, LEM, Hulme, WJ, Massey, J, MacDonald, O, Morley, J, Morton, CE, Park, RY, Walker, AJ, Ward, T, Wiedemann, M, Bates, C, Cockburn, J, Parry, J, Hester, F, Harper, S, Douglas, IJ, Evans, SJW, Goldacre, B, Tomlinson, LA, MacKenna, B
Format: Journal article
Language:English
Published: BMJ 2023

Similar Items